We are live on ! Find out more
SER icon

Serina Therapeutics

59 hedge funds and large institutions have $24.8M invested in Serina Therapeutics in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

32% more capital invested

Capital invested by funds: $18.7M → $24.8M (+$6.01M)

13% more funds holding

Funds holding: 5259 (+7)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% less ownership

Funds ownership: 0.49%0.48% (-0%)

19% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 16

Holders
59
Holders Change
+7
Holders Change %
+13.46%
% of All Funds
1.28%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
12
Increased
13
Reduced
16
Closed
5
Calls
Puts
Net Calls
Net Calls Change

SER Hedge Fund Activity: Q1 2019 in Review

59 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q1 2019, worth a combined $24.8M — up 32% from $18.7M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new SER positions and 5 closed out — a net gain of 7 holders — while 13 added to existing stakes and 16 trimmed.

The largest buyer was Price Capital Management, adding an estimated $182K. The largest seller was State of Wisconsin Investment Board, cutting an estimated $429K.

  • 59 institutional investors held Serina Therapeutics (SER) as of Q1 2019, up from 52 in Q4 2018.
  • Funds reported $24.8M of Serina Therapeutics stock for Q1 2019, up 32% quarter-over-quarter.
  • 12 funds opened new Serina Therapeutics positions in Q1 2019 and 5 closed out, a net change of +7 holders.
  • The largest Serina Therapeutics buyer in Q1 2019 was Price Capital Management, an estimated $182K added.
  • The largest Serina Therapeutics seller in Q1 2019 was State of Wisconsin Investment Board, an estimated $429K sold.

Based on aggregated 13F filings for Q1 2019.